Prudential PLC Cellectis S.A. Transaction History

Prudential PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$25.99 - $30.6 $2.47 Million - $2.91 Million	-95,156 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$27.78 - $38.53 $419,533 - $581,880	15,102 Added 18.86%	95,156 $2.69 Million
Q1 2018 May 15, 2018	SELL	$27.78 - $35.19 $202,627 - $256,675	-7,294 Reduced 8.35%	80,054 $2.52 Million
Q4 2017 Feb 14, 2018	BUY	$23.33 - $35.01 $2.04 Million - $3.06 Million	87,348	87,348 $2.55 Million

10.8M

5.9K

1.4K

Ticker CLLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,510,800
Market Cap $71M
Description
Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatm...

Get notified when there are updates to the investment portfolio of Prudential PLC, based on Form 13F filings with the SEC.

Stay updated on Prudential PLC with notifications on news.